{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T03:54:46Z","timestamp":1793850886821,"version":"4.6.1"},"reference-count":15,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T00:00:00Z","timestamp":1706832000000},"content-version":"unspecified","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Konung Gustaf V:s och Drottning Victorias Stiftelse","award":["Not Applicable"],"award-info":[{"award-number":["Not Applicable"]}]},{"name":"Stefan Paulssons foundation","award":["Not Applicable"],"award-info":[{"award-number":["Not Applicable"]}]},{"name":"Hudfonden foundation","award":["Not Applicable"],"award-info":[{"award-number":["Not Applicable"]}]},{"name":"Klapperup foundation","award":["Not Applicable"],"award-info":[{"award-number":["Not Applicable"]}]},{"name":"S.R. Gorthon foundation","award":["Not Applicable"],"award-info":[{"award-number":["Not Applicable"]}]},{"name":"Ingemar Perssons foundation","award":["Not Applicable"],"award-info":[{"award-number":["Not Applicable"]}]},{"name":"Regional research grants (Regionala Forskningsmedel) from Region Skane","award":["Not Applicable"],"award-info":[{"award-number":["Not Applicable"]}],"id":[{"id":"https:\/\/ror.org\/03sawy356","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100016874","name":"Liam M. Kinne Foundation","doi-asserted-by":"publisher","award":["Not Applicable"],"award-info":[{"award-number":["Not Applicable"]}],"id":[{"id":"10.13039\/100016874","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ALF","award":["2016-626231"],"award-info":[{"award-number":["2016-626231"]}]},{"name":"ALF","award":["2020-0019"],"award-info":[{"award-number":["2020-0019"]}]},{"name":"ALF","award":["2022-0285"],"award-info":[{"award-number":["2022-0285"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2024,1,17]]},"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Diagnosing invasive cutaneous melanoma (CM) can be challenging due to subjectivity in distinguishing equivocal nevi, melanoma in situ and thin CMs. The underlying molecular mechanisms of progression from nevus to melanoma must be better understood. Identifying biomarkers for treatment response, diagnostics and prognostics is crucial. Using biomedical data from biobanks and population-based healthcare data, translational research can improve patient care by implementing evidence-based findings. The BioMEL biobank is a prospective, multicentre, large-scale biomedical database on equivocal nevi and all stages of primary melanoma to metastases. Its purpose is to serve as a translational resource, enabling researchers to uncover objective molecular, genotypic, phenotypic and structural differences in nevi and all stages of melanoma. The main objective is to leverage BioMEL to significantly improve diagnostics, prognostics and therapy outcomes of patients with melanoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>The BioMEL biobank contains biological samples, epidemiological information and medical data from adult patients who receive routine care for melanoma. BioMEL is focused on primary and metastatic melanoma, but equivocal pigmented lesions such as clinically atypical nevi and melanoma in situ are also included. BioMEL data are gathered by questionnaires, blood sampling, tumour imaging, tissue sampling, medical records and histopathological reports.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The BioMEL biobank project is approved by the national Swedish Ethical Review Authority (Dnr. 2013\/101, 2013\/339, 2020\/00469, 2021\/01432 and 2022\/02421-02). The datasets generated are not publicly available due to regulations related to the ethical review authority.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT05446155\">NCT05446155<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2022-069694","type":"journal-article","created":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T01:26:38Z","timestamp":1706923598000},"page":"e069694","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":9,"title":["BioMEL: a translational research biobank of melanocytic lesions and melanoma"],"prefix":"10.1136","volume":"14","clinical-trial-number":[{"clinical-trial-number":"nct05446155","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct05446155","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02828202","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3730-2817","authenticated-orcid":false,"given":"Teo","family":"Helkkula","sequence":"first","affiliation":[{"name":"Dermatology and Venereology, Lund University Skin Cancer research group, Department of Clinical Sciences Lund, Lund University, Lund, Sweden"},{"name":"Department of Dermatology and Venereology, Sk\u00e5ne University Hospital Lund, Lund, Sweden"},{"name":"Lund Melanoma Study Group, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustav","family":"Christensen","sequence":"additional","affiliation":[{"name":"Dermatology and Venereology, Lund University Skin Cancer research group, Department of Clinical Sciences Lund, Lund University, Lund, Sweden"},{"name":"Department of Dermatology and Venereology, Sk\u00e5ne University Hospital Lund, Lund, Sweden"},{"name":"Lund Melanoma Study Group, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Ingvar","sequence":"additional","affiliation":[{"name":"Lund Melanoma Study Group, Lund University, Lund, Sweden"},{"name":"Department of Surgery, Department of Clinical Sciences Lund, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolin","family":"Isaksson","sequence":"additional","affiliation":[{"name":"Lund Melanoma Study Group, Lund University, Lund, Sweden"},{"name":"Department of Surgery, Department of Clinical Sciences Lund, Lund University, Lund, Sweden"},{"name":"Department of Surgery, Central Hospital in Kristianstad, Kristianstad, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8225-1510","authenticated-orcid":false,"given":"Katja","family":"Harbst","sequence":"additional","affiliation":[{"name":"Lund Melanoma Study Group, Lund University, Lund, Sweden"},{"name":"Department of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertil","family":"Persson","sequence":"additional","affiliation":[{"name":"Dermatology and Venereology, Lund University Skin Cancer research group, Department of Clinical Sciences Lund, Lund University, Lund, Sweden"},{"name":"Department of Dermatology and Venereology, Sk\u00e5ne University Hospital Lund, Lund, Sweden"},{"name":"Lund Melanoma Study Group, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5sa","family":"Ingvar","sequence":"additional","affiliation":[{"name":"Dermatology and Venereology, Lund University Skin Cancer research group, Department of Clinical Sciences Lund, Lund University, Lund, Sweden"},{"name":"Department of Dermatology and Venereology, Sk\u00e5ne University Hospital Lund, Lund, Sweden"},{"name":"Lund Melanoma Study Group, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Hafstr\u00f6m","sequence":"additional","affiliation":[{"name":"Lund Melanoma Study Group, Lund University, Lund, Sweden"},{"name":"Department of Otorhinolaryngology, wtih Head and Neck Surgery, Sk\u00e5ne University Hospital Lund, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Carneiro","sequence":"additional","affiliation":[{"name":"Lund Melanoma Study Group, Lund University, Lund, Sweden"},{"name":"Department of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden"},{"name":"Department of Oncology, Sk\u00e5ne University Hospital Lund, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoria","family":"Gaspar","sequence":"additional","affiliation":[{"name":"Dermatology and Venereology, Lund University Skin Cancer research group, Department of Clinical Sciences Lund, Lund University, Lund, Sweden"},{"name":"Lund Melanoma Study Group, Lund University, Lund, Sweden"},{"name":"Department of Pathology, Hospital in Helsingborg, Helsingborg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6ran","family":"J\u00f6nsson","sequence":"additional","affiliation":[{"name":"Lund Melanoma Study Group, Lund University, Lund, Sweden"},{"name":"Department of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7363-0455","authenticated-orcid":false,"given":"Kari","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Dermatology and Venereology, Lund University Skin Cancer research group, Department of Clinical Sciences Lund, Lund University, Lund, Sweden"},{"name":"Department of Dermatology and Venereology, Sk\u00e5ne University Hospital Lund, Lund, Sweden"},{"name":"Lund Melanoma Study Group, Lund University, Lund, Sweden"},{"name":"Department of Dermatology and Venereology, Hospital in Helsingborg, Helsingborg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,2,2]]},"reference":[{"key":"2025121510074003000_14.2.e069694.1","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13112838","article-title":"Trend shifts in age-specific incidence for in situ and invasive Cutaneous Melanoma in Sweden","volume":"13","author":"Eriksson","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2025121510074003000_14.2.e069694.2","unstructured":"Socialstyrelsen . Cancer i siffror 2018, Available: https:\/\/www.socialstyrelsen.se\/globalassets\/sharepoint-dokument\/artikelkatalog\/statistik\/2018-6-10.pdf"},{"key":"2025121510074003000_14.2.e069694.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.08.055"},{"key":"2025121510074003000_14.2.e069694.4","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(02)00679-4"},{"key":"2025121510074003000_14.2.e069694.5","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.j2813","article-title":"Pathologists\u2019 diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study","volume":"357","author":"Elmore","year":"2017","journal-title":"BMJ"},{"key":"2025121510074003000_14.2.e069694.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2018.06.005"},{"key":"2025121510074003000_14.2.e069694.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1502583"},{"key":"2025121510074003000_14.2.e069694.8","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/25.2.245"},{"key":"2025121510074003000_14.2.e069694.9","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0215(20000701)87:1<145::AID-IJC22>3.0.CO;2-3"},{"key":"2025121510074003000_14.2.e069694.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0738-081X(02)00216-X"},{"key":"2025121510074003000_14.2.e069694.11","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.134.12.1563"},{"key":"2025121510074003000_14.2.e069694.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)70528-1"},{"key":"2025121510074003000_14.2.e069694.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.05.044"},{"key":"2025121510074003000_14.2.e069694.14","unstructured":"Follow-up of a National Cohort of Melanoma Stage IV and Unresectable Stage III Patients (MelBase). Available: https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT02828202"},{"key":"2025121510074003000_14.2.e069694.15","unstructured":"Nationellt kvalitetsregister hudmelanom (SweMR). 2022. Available: https:\/\/cancercentrum.se\/samverkan\/cancerdiagnoser\/hud-och-melanom\/malignt-melanom\/kvalitetsregister"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2022-069694","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T18:07:49Z","timestamp":1765822069000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2022-069694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":15,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2,2]]},"published-print":{"date-parts":[[2024,2]]}},"alternative-id":["10.1136\/bmjopen-2022-069694"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2022-069694","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2]]}}}